
    
      Patients will be randomized in a 1:1 ratio to the following monthly treatment groups:

        -  Zimura 2 mg

        -  Sham

      At month 12, the patients in the Zimura 2mg treatment group will be re-randomized to receive
      the study drug either on a monthly basis or on an every other month basis

      The patients initially randomized to Sham treatment will continue with monthly Sham
      injections through Month 23

      All patients will have a final follow up visit at Month 24
    
  